• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

Al-Futtaim Partners with TytoCare to Expand Digital Health Services

by Jasmine Pennic 01/24/2022 Leave a Comment

COVID-19 Spikes Deaconess Health Adoption of Remote Medical Exams

What You Should Know: - TytoCare, a global all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams, announced today its partnership with Al-Futtaim Electronic-Techserve, a group company of Al-Futtaim. The partnership with TytoCare will enable Al-Futtaim to broaden its reach across the healthcare spectrum, covering all touchpoints, from specialists to local clinics. - Al-Futtaim Group is a large
Read More

Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine

by Prakriteswar Santikary, Ph.D., VP of Engineering and Technology at ConcertAI 01/24/2022 Leave a Comment

Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine

Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the advances while ensuring safeguards are in place. As artificial intelligence (AI) and machine learning drive innovation and disruption in clinical trials and precision medicine, questions around the responsible use of AI have moved to the forefront of debates among healthcare stakeholders – patients, providers, regulatory authorities, payors and sponsors. To what extent,
Read More

Casana Raises $30M for Effortless Home Health Monitoring

by Fred Pennic 01/21/2022 Leave a Comment

Casana Raises $14 Million for In-home Heart Health Monitoring Device

What You Should Know: - Casana, a healthcare technology firm that is reinventing in-home health monitoring announced it has raised $30M in Series B funding, bringing the total capital raised to $46 million led by Morningside with participation from Matrix Partners, as well as Series A investors General Catalyst and Outsiders Fund. - The Series B funding will allow Casana to accelerate FDA submission of the Heart Seat with the goal to obtain FDA approval and bring this important new device
Read More

Capital Rx, Independa, and LG TV Partner to Bring Discount Prescription Meds to Older Adults

by Jasmine Pennic 01/21/2022 Leave a Comment

Capital Rx, Independa, and LG TV Partner to Bring Discount Prescription Meds to Older Adults

What You Should Know: - Capital Rx is partnering with Independa, a telehealth engagement platform for seniors, to bring its prescription savings card to the older adult population via LG TVs. - Independa, a provider of TV-based remote engagement, education and care, and LG Electronics, a global leader in TV manufacturing, together launched the Independa Health Hub™ Ecosystem of Healthy Offerings on LG TVs at the 2022 Consumer Electronics Show. In introducing the Capital Rx Advantage
Read More

Alphabet’s Verily + L’Oréal Partner to Advance Precision Skin Health

by Fred Pennic 01/20/2022 Leave a Comment

Alphabet’s Verily + L’Oréal Partner to Advance Precision Skin Health

What You Should Know: - Today, Alphabet’s Verily, a world leader in personalized medicine, and L’Oréal, the world leader in beauty, joined forces to lead a new era of precision skin health. - The first-of-its-kind partnership in the beauty industry aims to break down barriers to dermatology care and bring new insights to dermatologists that can help improve health outcomes for the nearly two billion people worldwide with skin issues. Strategic Partnership Addresses Unmet Need in
Read More

DarioHealth Acquires Physimax, AI-Powered Musculoskeletal Self-Assessment and Optimization Platform

by Fred Pennic 01/20/2022 Leave a Comment

DarioHealth Acquires Physimax, AI-Powered Musculoskeletal Self-Assessment and Optimization Platform

What You Should Know: - Global digital therapeutics (DTx) company DarioHealth Corp. (Nasdaq: DRIO), a leader in the market (the Company), announced it has entered into an agreement to purchase all of the right, title and interest in certain assets of Physimax Technologies Ltd. ("Physimax"), a leading provider of computer vision (CV) technology for Musculoskeletal (MSK) functional screening and predictive risk of injury assessment. - This acquisition complements DarioHealth’s existing MSK
Read More

Theranica Publishes Largest Ever Real-World Study of a Migraine Device

by Fred Pennic 01/20/2022 Leave a Comment

Theranica Publishes Largest Ever Real-World Study of a Migraine Device

What You Should Know: - Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced today the publication of a new peer-reviewed study analyzing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication adjunct, treatment of migraine. - The real-world evidence study published in Frontiers in Pain Research Journal concludes that REN, administered by
Read More

Syapse, Pfizer Extends Collaboration to Generate Real-World Evidence in Breast Cancer

by Jasmine Pennic 01/20/2022 Leave a Comment

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

What You Should Know: - Syapse, a real-world evidence company that informs cancer care, announced that it will extend its collaboration with Pfizer to generate real-world evidence in breast cancer. - This is the third phase of the collaboration, which was first announced in 2019 and renewed in 2021. Generate Real-World Evidence in Breast Cancer As part of the next phase of the collaboration, Syapse will provide insights and services to Pfizer, using the Syapse Learning Health Network
Read More

Blue Shield of California Adds Ginger to Expand Mental Health Support

by Jasmine Pennic 01/20/2022 Leave a Comment

Blue Shield of California Adds Ginger to Expand Mental Health Support

What You Should Know: - Blue Shield of California today announced that its health plan members who are enrolled in the Wellvolution program now have access to Headspace Health's Ginger on-demand, personalized mental health support that can be accessed on their smartphone. - Ginger is an on-demand mental health platform that can help individuals manage anxiety, depression, sleep problems, and other mental health challenges. The service provides eligible Blue Shield members easy access to
Read More

Platform Launches to Help Eliminate Biases in Decentralized Trials

by HITC Staff 01/20/2022 Leave a Comment

Platform Launches to Help Clinical Raters Eliminate Biases in Decentralized Trials

What You Should Know: - Obviohealth, a decentralized clinical trial platform, has launched a new AI-assisted clinical raters platform to eliminate biases from trials. The platform Augmented ePRO (electronic patient-reported outcomes), has been designed to assist clinical raters to better score patient outcomes, without biases. Why It Matters As more trials take place virtually or decentralized, clinical researchers are at the mercy of the quality of the information provided by the
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 350
  • Go to page 351
  • Go to page 352
  • Go to page 353
  • Go to page 354
  • Interim pages omitted …
  • Go to page 738
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |